Get Premium to unlock powerful stock data

Deciphera Pharmaceuticals Inc (DCPH) CFO Thomas Patrick Kelly Sold $662,280 of Shares

Author's Avatar
May 13, 2020
Article's Main Image

CFO of Deciphera Pharmaceuticals Inc (30-Year Financial, Insider Trades) Thomas Patrick Kelly (insider trades) sold 12,000 shares of DCPH on 05/11/2020 at an average price of $55.19 a share. The total sale was $662,280.

Deciphera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients. Deciphera Pharmaceuticals Inc has a market cap of $2.71 billion; its shares were traded at around $48.44 with and P/S ratio of 73.94. GuruFocus has detected 1 severe warning sign with Deciphera Pharmaceuticals Inc. .

CFO Recent Trades:

  • CFO Thomas Patrick Kelly sold 12,000 shares of DCPH stock on 05/11/2020 at the average price of $55.19. The price of the stock has decreased by 12.23% since.

Directors and Officers Recent Trades:

  • Director Michael Douglas Taylor sold 25,000 shares of DCPH stock on 04/28/2020 at the average price of $56.9. The price of the stock has decreased by 14.87% since.
  • Director Michael Douglas Taylor sold 23,892 shares of DCPH stock on 04/17/2020 at the average price of $46.67. The price of the stock has increased by 3.79% since.
  • Director Michael Douglas Taylor sold 1,108 shares of DCPH stock on 04/14/2020 at the average price of $46.71. The price of the stock has increased by 3.7% since.

For the complete insider trading history of DCPH, click here

.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus